Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment and Tracking of Long-term Alefacept (LFA-3/IgG1 Fusion Protein) Safety (ATLAS)

NCT00454701 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.

NCT NCT00454701
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00454701 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment and Tracking of Long-term Alefacept (LFA-3/IgG1 Fusion Protein) Safety (ATLAS)
Lead sponsor
Astellas Pharma Inc
Phase
Observational
Overall status
Terminated
Start date
June 30, 2003
Completion date
February 29, 2012
Enrollment
1,897 (actual)
Sites
268

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis